JP3393559B2 - Skin preparation - Google Patents

Skin preparation

Info

Publication number
JP3393559B2
JP3393559B2 JP28160093A JP28160093A JP3393559B2 JP 3393559 B2 JP3393559 B2 JP 3393559B2 JP 28160093 A JP28160093 A JP 28160093A JP 28160093 A JP28160093 A JP 28160093A JP 3393559 B2 JP3393559 B2 JP 3393559B2
Authority
JP
Japan
Prior art keywords
skin
symptoms
observed
derivatives
roughness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP28160093A
Other languages
Japanese (ja)
Other versions
JPH07138142A (en
Inventor
二郎 岡部
増美 竹井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP28160093A priority Critical patent/JP3393559B2/en
Publication of JPH07138142A publication Critical patent/JPH07138142A/en
Application granted granted Critical
Publication of JP3393559B2 publication Critical patent/JP3393559B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、皮膚のしわ,しみ,き
めの粗さ,かさつき,ざらつきといった老化症状の防
止,改善、及び肌荒れ症状の改善等に有効な皮膚外用剤
に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation effective for preventing and improving aging symptoms such as wrinkles, spots, roughness of texture, roughness and roughness of skin, and improving rough skin symptoms.

【0002】[0002]

【従来の技術】従来より、皮膚のしわ,しみ,きめの粗
さ,かさつき,ざらつきといった老化症状の防止,改善
や、肌荒れ症状を改善するための皮膚外用剤について
は、多くの研究がなされてきた。最近、皮膚外用剤の分
野において、皮膚細胞自体を賦活し、皮膚の機能そのも
のを活性化して、皮膚症状の改善や老化防止を図る試み
がなされている。
2. Description of the Related Art Conventionally, many studies have been conducted on external preparations for the skin to prevent or improve aging symptoms such as wrinkles, spots, roughness of the skin, roughness, and roughness of the skin, and to improve rough skin symptoms. Came. Recently, in the field of external preparations for skin, attempts have been made to activate skin cells themselves and activate the functions of the skin itself to improve skin symptoms and prevent aging.

【0003】かかる試みとして、ホルモン類,各種ビタ
ミン類,生薬抽出物,動物臓器抽出物,植物抽出物等に
皮膚細胞賦活剤が求められてきた。なかでも、結合組織
の構成タンパク質であるコラーゲンやエラスチンを添加
したり、線維芽細胞の活性化を図るべく可溶性卵殻膜を
用いた化粧料等が提案されている(特公昭60−197
25,特開昭48−40943,特開平3−19080
8)。また、われわれはグリコール酸,乳酸をはじめと
するα−ヒドロキシ酸又はこれらの塩、あるいはステロ
ールエステル等の誘導体が線維芽細胞の増殖を促進し、
皮膚の老化の防止,改善に有効であることを見い出し、
開示している(特開平5−112422,特願平5−1
57843)。
As such attempts, skin cell activators have been sought for hormones, various vitamins, herbal medicine extracts, animal organ extracts, plant extracts and the like. Among them, cosmetics and the like in which collagen or elastin, which is a constituent protein of connective tissue, are added, and a soluble eggshell membrane is used to activate fibroblasts have been proposed (Japanese Patent Publication No. 60-197).
25, JP-A-48-40943, JP-A-3-19080.
8). In addition, we have found that α-hydroxy acids such as glycolic acid and lactic acid, or their salts, or derivatives such as sterol esters promote the proliferation of fibroblasts,
It was found to be effective in preventing and improving skin aging,
Japanese Patent Application Laid-Open No. 5-112422, Japanese Patent Application No. 5-1
57843).

【0004】[0004]

【発明が解決しようとする課題】しかし、上記したよう
な皮膚細胞賦活剤においては、副作用の問題から使用に
際し制限を受けたり、作用・効果が十分でなく、かなり
大量を配合しなければならなかったり、といった問題点
があった。また、植物や動物由来物質においては特に品
質の管理が困難で、安定な皮膚賦活剤の提供を受けるこ
とが難しく、さらに皮膚外用剤として他の成分とともに
配合して製剤化した場合に、活性が失われてしまうもの
もあった。特に、コラーゲンやエラスチン,可溶性卵殻
膜等はタンパク質より成るため、感作性という面でも問
題があった。α−ヒドロキシ酸類についても、配合量を
多くすると皮膚刺激性が出現したり、皮膚吸収等の問題
で期待通りの作用効果の得られないこともあった。
However, in the above skin cell activating agent, there is a limitation in use due to the problem of side effects, the action and effect are not sufficient, and a considerably large amount must be blended. There were problems such as. In addition, it is particularly difficult to control the quality of substances derived from plants or animals, and it is difficult to receive a stable skin activating agent. Furthermore, when formulated as a skin external preparation with other ingredients, the activity is Some were lost. In particular, since collagen, elastin, soluble eggshell membranes, etc. consist of proteins, there is a problem in terms of sensitization. With respect to the α-hydroxy acids, too, when the compounding amount is increased, skin irritation may appear, and due to problems such as skin absorption, the expected effects may not be obtained.

【0005】[0005]

【課題を解決するための手段】上記の課題を解決し、副
作用や皮膚等への刺激など、好ましくない影響のない皮
膚外用剤を提供するべく鋭意検討したところ、線維芽細
胞活性化作用を有するグリコール酸,その塩(エタノー
ルアミン及びその誘導体との塩を除く)及び誘導体の1
種以上と、卵殻膜より抽出したタンパク質とを併用する
ことにより、それぞれ少量の配合量で相乗的な線維芽細
胞の増殖促進が認められた。
[Means for Solving the Problems] In order to solve the above-mentioned problems and to provide an external preparation for the skin free of adverse effects such as side effects and irritation to the skin, etc., it has been found to have a fibroblast activating effect. Glycolic acid, its salt
Lumin and its derivatives (except salts) and 1 of its derivatives
By using the seeds and above together with the protein extracted from the eggshell membrane, synergistic promotion of fibroblast proliferation was observed with a small amount of each.

【0006】α−ヒドロキシ酸としては、グリコール
酸,その塩(エタノールアミン及びその誘導体との塩を
除く)や、ステロールとのエステル等の誘導体も用いる
ことができる。
As the α-hydroxy acid, glycol is used.
Acids, their salts (salts with ethanolamine and its derivatives
Except), and derivatives such as esters with sterols can also be used.

【0007】本発明においては、卵殻膜として鶏卵,う
ずら卵等の鳥類の卵殻の内側に付着している膜を用い、
これより酸剤,アルカリ剤,有機溶媒等により可溶化抽
出されるタンパク質を用いる。
In the present invention, a film attached to the inside of the eggshell of birds such as chicken eggs and quail eggs is used as the eggshell membrane,
Proteins that are solubilized and extracted with acid agents, alkaline agents, organic solvents, etc. are used.

【0008】各成分の配合量は、それぞれ単独で使用す
る場合よりもはるかに少量で有効な作用を発揮させるこ
とができる。グリコール酸,その塩(エタノールアミン
及びその誘導体との塩を除く)又はこれらの誘導体は1
0の−6乗重量%〜10重量%、卵殻膜抽出タンパク質
の配合量は0.00001〜10重量%程度が適当であ
る。また、皮膚外用剤に通常使用される他の成分をも併
用して配合することができ、外用剤の形態としては、化
粧水,皮膚用乳液,皮膚用クリーム,軟膏等の形態を採
ることができ、化粧料としても提供し得る。
[0008] The effective amount of each component can be exerted in a much smaller amount than when used alone. Glycolic acid, its salt (ethanolamine
And salts thereof and its derivatives are 1
0-6th to 10% by weight, egg shell membrane extracted protein
It is suitable that the compounding amount of 0.00001 to 10% by weight.
It In addition, other components that are usually used in external preparations for skin can be used in combination, and the external preparations may take the form of lotion, skin emulsion, skin cream, ointment and the like. It can be provided as a cosmetic.

【0009】[0009]

【作用】本発明による皮膚外用剤を適用すると、真皮線
維芽細胞の増殖促進作用が相乗的に強化され、しわ,し
みの消失、きめの粗さ,かさつき,ざらつきの改善等、
優れた皮膚の老化症状の防止及び改善、肌荒れ症状の改
善が認められる。
When the external preparation for skin according to the present invention is applied, the dermal line
The growth promoting action of fibroblasts is synergistically enhanced, resulting in wrinkles and wrinkles.
Loss of texture, roughness of texture, improvement of roughness and roughness, etc.
Excellent prevention and improvement of skin aging symptoms, improvement of rough skin symptoms
Goodness is recognized.

【0010】[0010]

【実施例】さらに、本発明の特徴について実施例により
詳細に説明する。まず、本発明による美容化粧水として
実施例1の処方を、比較例1及び2の処方とともに表1
に示す。表1中、(1)〜(9)の成分を(11)に混合,溶解し
て均一とし、(10)を添加した後(11)で全量を100重量
%とする。
EXAMPLES Further, the features of the present invention will be described in detail with reference to Examples. First, as a beauty lotion according to the present invention, the formulation of Example 1 and the formulations of Comparative Examples 1 and 2 are shown in Table 1.
Shown in. In Table 1, the components (1) to (9) are mixed with (11) and dissolved to homogenize, and after adding (10), the total amount is 100% by weight in (11).

【0011】[0011]

【表1】 [Table 1]

【0012】上記の実施例及び比較例について、皮膚の
老化症状の改善効果及び皮膚の荒れ症状の治癒効果を検
討した。まず、皮膚の老化症状の改善は、各試料につい
て、かかる症状が顕著に認められる50〜60才代の男
女パネラー20名ずつにブラインドにて1カ月間使用さ
せ、使用の前後の皮膚状態の変化を観察して評価した。
皮膚の老化症状の指標として、皮膚のしわ,しみ,き
め,はりの4項目を選び、しわ,しみ,きめについては
写真撮影及び皮膚表面のレプリカにより観察し、改善状
況を評価した。皮膚のはりについては、皮膚弾性の測定
により評価した。改善状況は、「A;改善」,「B;や
や改善」,「C;変化なし」の三段階で評価し、実施例
1及び比較例1,2について表2に、各評価を得たパネ
ラー数にて示した。
With respect to the above Examples and Comparative Examples, the effect of improving skin aging symptoms and the effect of healing rough skin symptoms were examined. First, for the improvement of skin aging symptoms, for each sample, 20 male and female panelists in their 50s to 60s, in which such symptoms were noticeably used, were blindly used for 1 month, and the skin condition was changed before and after use. Was observed and evaluated.
As an index of skin aging symptoms, four items of skin wrinkles, spots, texture, and acupuncture were selected, and wrinkles, spots, and texture were observed by taking photographs and replicas of the skin surface, and the improvement status was evaluated. The skin elasticity was evaluated by measuring the skin elasticity. Improvements situation, "A;improvement","B: slightly improved"; and evaluated in three levels: "C no change", Example
The panel which obtained each evaluation in Table 2 about 1 and Comparative Examples 1 and 2.
It is shown by the Ra number.

【0013】[0013]

【表2】 [Table 2]

【0014】表2においては、α−ヒドロキシ酸の1種
であるグリコール酸と卵殻膜抽出タンパク質を併用する
実施例1が、それぞれ単独で配合する比較例1又は2に
比べて、顕著に皮膚のしわ,きめ,はりを改善すること
が示されている。皮膚のしみについても、85%のパネ
ラーにおいて改善傾向を認めており、7名については明
らかな改善が認められた。実施例1においては、グリコ
ール酸及び卵殻膜抽出タンパク質をわずかに0.2重量
%ずつ配合するのみで、かかる顕著な相乗効果が認めら
れた。
In Table 2, Example 1 in which glycolic acid, which is one of α-hydroxy acids, and egg shell membrane-extracted protein are used in combination is markedly different from that in Comparative Example 1 or 2 in which they are mixed alone. It has been shown to improve wrinkles, texture and acupuncture. Regarding the skin stains, an improvement tendency was observed in 85% of the panelists, and a clear improvement was observed in 7 persons. In Example 1, such a remarkable synergistic effect was observed by only adding 0.2% by weight of glycolic acid and the protein extracted from eggshell membrane.

【0015】次に、皮膚の荒れ症状の治癒効果について
は、マウス背部皮膚を5重量%のラウリル硫酸ナトリウ
ム水溶液により処理して、鱗状の荒れ症状を人工的に惹
起し、これに各試料を1日2回、5日間連続塗布して、
治癒状況を観察して評価した。各試料につき10匹のマ
ウスを用い、荒れ症状の治癒状況を「完全治癒」,「や
や治癒」,「変化なし」の三段階で評価し、各評価を得
たマウスの数にて表3に示した。
Next, regarding the healing effect of the rough skin condition, the dorsal skin of the mouse was treated with an aqueous solution of 5% by weight of sodium lauryl sulfate to artificially induce the scale-like rough condition, and 1 sample of each sample was added thereto. Apply twice a day for 5 consecutive days,
The healing situation was observed and evaluated. Ten mice were used for each sample, and the healing status of the rough symptom was evaluated in three grades of "complete cure", "moderate cure", and "no change", and the number of mice obtained each evaluation is shown in Table 3 . Indicated.

【0016】[0016]

【表3】 [Table 3]

【0017】表3において、グリコール酸及び卵殻膜抽
出タンパク質を併用する実施例1では、すべてののマウ
スにおいて完全治癒を認めた。これに対し、前記各成分
を単独で配合する各比較例では、ある程度の治癒を認め
たマウスはよくても半数にとどまり、ほとんど治癒の認
められない場合もあった。
In Table 3, glycolic acid and eggshell membrane extraction
In Example 1 in which the protein produced is used in combination,
A complete cure was observed in the suture. In contrast, each of the above components
Some healing was observed in each comparative example in which
At best, only half of the mice showed good healing
In some cases, it was not possible.

【0018】[0018]

【発明の効果】以上のように本発明において、グリコー
ル酸,その塩(エタノールアミン及びその誘導体との塩
を除く)及び誘導体と卵殻膜抽出タンパク質とを併用す
ることにより、それぞれ非常に少量の配合で、各単独で
用いる場合に比べ皮膚の老化症状,荒れ肌症状の相乗的
な改善効果が認められた。従って、皮膚刺激や皮膚感作
性のない、極めて安全で効果に優れた老化防止、皮膚症
状改善用の皮膚外用剤を提供することができた。
As described above, in the present invention, glyco
Acid, its salt (salt with ethanolamine and its derivatives
, Except) and derivatives together with egg shell membrane extracted protein
As a result, it is possible to add a very small amount of each, and
Synergistic effect of skin aging and rough skin compared to when used
A significant improvement effect was observed. Therefore, it was possible to provide an extremely safe and highly effective external preparation for skin for preventing aging and improving skin symptoms, which is free from skin irritation and skin sensitization.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平5−163132(JP,A) 特開 平5−112422(JP,A) 特開 平3−190808(JP,A) 特開 昭48−40943(JP,A) 特開 昭48−40968(JP,A) 特開 昭60−214719(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 CA(STN)─────────────────────────────────────────────────── --Continued from the front page (56) References JP-A-5-163132 (JP, A) JP-A-5-112422 (JP, A) JP-A-3-190808 (JP, A) JP-A-48- 40943 (JP, A) JP 48-40968 (JP, A) JP 60-214719 (JP, A) (58) Fields investigated (Int.Cl. 7 , DB name) A61K 7/00-7 / 50 CA (STN)

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 グリコール酸,その塩(エタノールアミ
ン及びその誘導体との塩を除く)及び誘導体から成る群
から選んだ1種以上と、卵殻膜より抽出して得たタンパ
ク質とを配合することを特徴とする皮膚外用剤。
1. Glycolic acid, its salt (ethanolami)
And a derivative thereof, and at least one selected from the group consisting of derivatives, and a protein obtained by extracting from eggshell membranes.
【請求項2】 皮膚外用剤が化粧料であることを特徴と
する、請求項1に記載の皮膚外用剤。
2. The external preparation for skin according to claim 1, wherein the external preparation for skin is a cosmetic.
JP28160093A 1993-10-15 1993-10-15 Skin preparation Expired - Fee Related JP3393559B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28160093A JP3393559B2 (en) 1993-10-15 1993-10-15 Skin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28160093A JP3393559B2 (en) 1993-10-15 1993-10-15 Skin preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2001375536A Division JP2002212069A (en) 2001-12-10 2001-12-10 Skin care perparation

Publications (2)

Publication Number Publication Date
JPH07138142A JPH07138142A (en) 1995-05-30
JP3393559B2 true JP3393559B2 (en) 2003-04-07

Family

ID=17641412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28160093A Expired - Fee Related JP3393559B2 (en) 1993-10-15 1993-10-15 Skin preparation

Country Status (1)

Country Link
JP (1) JP3393559B2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686489A (en) * 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
JPH07238010A (en) * 1994-02-24 1995-09-12 Kanebo Ltd Skin cosmetic
JPH07291850A (en) * 1994-04-26 1995-11-07 Kanebo Ltd Skin cosmetic
DE19543695A1 (en) * 1995-11-23 1997-05-28 Beiersdorf Ag Compositions based on alpha-hydroxyalkanoic acids and squalene, effective against bacteria, Mycota and viruses
JPH09301883A (en) * 1996-05-15 1997-11-25 Ichimaru Pharcos Co Ltd Cell activator containing blackberry lily extract and alpha-hydroxyl acid and its application
JPH09301884A (en) * 1996-05-15 1997-11-25 Ichimaru Pharcos Co Ltd Testosterone 5 alpha-reductase inhibitor containing blackberry lily extract and alpha-hydroxyl acid and its application
JP3864470B2 (en) * 1996-11-29 2006-12-27 キユーピー株式会社 Antioxidant composition and food or feed containing the same
JP2004203812A (en) * 2002-12-26 2004-07-22 Kanebo Ltd Oral composition and bleaching agent containing the same as essential component
US8114829B2 (en) 2005-02-22 2012-02-14 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US7566693B2 (en) 2005-02-22 2009-07-28 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
WO2007030145A2 (en) * 2005-03-29 2007-03-15 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US8642578B2 (en) 2005-03-29 2014-02-04 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
GB0921001D0 (en) 2009-11-30 2010-01-13 Aqua Bio Technology Asa Products and uses
JP2012153614A (en) * 2011-01-24 2012-08-16 Unitika Ltd Collagen production promoter
US11992508B2 (en) 2014-10-28 2024-05-28 Biovotec As Micronized eggshell membrane particles and the use thereof to promote the healing of wounds
EP3313464B1 (en) 2015-06-24 2020-08-26 Biovotec AS Tissue engineering scaffolds comprising particulate egg shell membrane
GB201519923D0 (en) 2015-11-11 2015-12-23 Biovotec Dac And Biovotec As Dry biocompatible disintegrateable films for delivering particulate egg shell membrane to a wound

Also Published As

Publication number Publication date
JPH07138142A (en) 1995-05-30

Similar Documents

Publication Publication Date Title
JP3393559B2 (en) Skin preparation
CN1893911B (en) Formula including tetrapeptide and tripeptide mixture
JP5010775B2 (en) Use of ellagic acid and its derivatives in cosmetics and dermatology
JP3434333B2 (en) Skin preparation
JP7307835B2 (en) aqueous composition
JP2002542178A (en) Skin care compositions containing combinations of skin care actives
JP2002544217A (en) Method for adjusting the state of mammalian keratinous tissue by topical application of phytosterol composition
JP2003530302A (en) Skin care composition containing a combination of skin care actives
JP2002542177A (en) Methods for regulating the state of keratinous tissue in mammals
DE112007001469T5 (en) Collagen Synthesis Promoter Containing Zinc as an Active Ingredient
US20090220603A1 (en) Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
JP2002293747A (en) Skin preparation for external use
JP2002542179A (en) Skin care compositions containing combinations of skin care actives
JP2001131049A (en) Skin preparation for external use
JPH09183718A (en) Composition suitable for external application
US5637606A (en) Hair grower based on allantoin or derivatives thereof
CN109846756A (en) A kind of moisturizing emulsion of the extract containing beeswax and preparation method thereof
JPH11139951A (en) Cosmetic
JP2000229835A (en) Cosmetic material for improving dullness
JPH06279294A (en) Collagen synthesis promoter
JP3678415B2 (en) Skin preparation
JP3507635B2 (en) Composition suitable for external use
JP2002212069A (en) Skin care perparation
JP3897600B2 (en) Topical skin preparation
JP2000109417A (en) Cosmetic for improving somber color

Legal Events

Date Code Title Description
RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7425

Effective date: 20060106

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

A072 Dismissal of procedure

Free format text: JAPANESE INTERMEDIATE CODE: A072

Effective date: 20060308

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080131

Year of fee payment: 5

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D05

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090131

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090131

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100131

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100131

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110131

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120131

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees